predominant mode of screening,” said corresponding author Dr. Ilana Richman, an assistant professor at Yale School of Medicine in New Haven, Conn.
While evidence suggests DBT may improve cancer detection rates and reduce false-positive results, more research is needed to assess its impact on breast cancer deaths, the authors noted.
“Although there is a lot of interest in this new technology, we don’t know much about how it will affect the long-term health of women,” Richman said in a Yale news release. “There are ongoing studies designed to answer these questions, and we hope to have clearer answers in the next few years.”
Two groups that provide guidance to doctors about cancer screening — the U.S. Preventive Services Task Force and the American Cancer Society — have not recommended for or against the routine use of DBT.
But the researchers said these new findings, published June 24 in the